FILE PHOTO: A pharmacist displays a box of Ozempic, a semaglutide injection type 2 drug used for treating diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo
FILE PHOTO: A pharmacist displays a box of Ozempic, a semaglutide injection type 2 drug used for treating diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo